Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Leo could have kept his mouth shut when announcing an application to up-list... He showed his hand to the shorts... 2 months CTIX qualified to up-list, however, Leo didn't have the BOD's in place until April... When the BOD's came onboard the shorts knocked the price down to 2.50... Price rebounds back over 3, then the short attackers kick in their strategy (SA bear attack)... The SA article was so detailed it had to be in discussion/planning for many weeks.
I agree, Only way to reverse this downtrend is to up-list with a RS or a partnership deal. Otherwise, this is a sinking ship...
Panic selling? 200 million plus shares out-standing. This is more ZERO interest in buyers. Plenty of time to buy later on after Leo makes a major move. Either, partnership or a RS to up-list. If not, the short attacks continue...
Polymedix had promise also... Example of how things can go wrong even if you have great science. I've stressed proper management the past year on this board. Most of the time I was bashed for getting on Leo. Well, Leo might of had good intentions for being so transparent, but it also does no good if you can't deliver. Why say anything about up-listing until your approved? The shorts know exactly what's going on and when to act... Bad strategy...
Can't halt the stock... OTC pink sheets only has 4 halts in place. Most are compliance with the SEC...
I mentioned up-listing to the Amex NY exchange back in April. They qualified back then, not now as the PPS is too low. Again, Leo counted on a stable PPS to help fund the company and eventually up-list. Did not work out, the SA article killed the company in half. Now the wait is until mid September for news? Great...
Yes, the scared tactics have worked... Leo lost total control since the SA article. There's a fine line in this business and Leo was unprepared and late to up-list. He took a risk of exactly what has happened... Trapped in penny land with no way out.
Really? The only ones benefiting by owning shares the past 3 weeks has been shorts. 2 articles cut the market cap in half. Not what I call a safe investment right now. Leo had his chance to up-list and chose to stay on-the-pinks. Worst decision he ever made...
When is the RS? Leo is out of all options now... Stock is too easily controlled by a few shorts.
Same trading pattern every day. Down off-the-start, makes a little recovery, MM's kill the recovery last 10 minutes of trading. Totally rigged market... Leo needs to up-list ASAP regardless of how.
Nothing seems to be helping now... Don't underestimate what a higher and stable PPS means. We all know CTIX is under attack, Leo holds the next move... We will see how he responds. Hopefully, with better results than his last 2 press releases.
Yes, price swings can happen, but good news has not brought value to CTIX shares this year. Why? the biggest reason is little exposure and no security when trading on the pinks.
Really, do you know Nasdaq has trading halts that would support a bear raid? The big decline from the SA article would have been contained. Stocks trading on the Nasdaq, above 5 bucks can draw more interest from real investment. Not the garbage that trades on the pinks. The argument that this would have happened "the PPS being cut in half" on the Nasdaq is without base.
The naysayers? Most posts here have been supportive of the company. Probably, 95 percent have been positive since the SA article. The question is how can Leo gain back trust in the stock. Again, my opinion, the best way is to move off the pinks... Been that way sine we hit a high of almost 5, to the low a few weeks back. The problem is that a "few naysayers" have more control of CTIX stock than the CEO of late...
If the PPS was/is the only holdup for up-listing, then nothing has changed other than the PPS. Again, some of us feared this would happen by staying on-the-pinks. Fear being a bear attack raid where Leo wouldn't have any control. The pink sheets could be the single biggest reason why CTIX would/might have to fold...
Really, so the other alternative is letting the PPS be controlled by shorts? Down 60 percent YTD, with so much good news? I would take my chances up-listing to a better market....
If Leo can up-list by doing a RS, that would be the best medicine to get rid of the shorts. If he did this back in May, we would be in much better position than today....
Heavy volume, Not sure where this goes from here? Leo will have no choice but to do a RS. He helped cause all this by not up-listing a few months ago. Better to have taken the initial hit, then be held hostage by short sellers.
Should have had those guys hold today's newspaper? LOL
The naysayers won't believe it...
Dr Krisha Menon's resume speaks volumes of how lucky we are to have him on-board. Those criminals who tried to burn his name will be the losers. There's been some discussion on partnerships, what better connection than Lilly or Bayer who he worked for... Menon was responsible for 7 FDA approvals, 3 blockbusters...
https://www.crunchbase.com/person/krishna-menon
Dr. Menon was originally trained as a veterinary surgeon. He was Director of Agriculture for Cayman Islands, in the British Caribbean during 1978-1981. Thereafter he came to the Dana Farber Cancer Research Institute and obtained a PhD in Pharmacology in 1984 from Harvard University. He worked under the direction of Nobel Laureate Dr. Tom Frye. His PhD work involved anti-folate therapy of various cancers, which has led to the extremely important drugs, methotrexate and recently, the blockbuster Alimta. He was Research Scientist at Dana Farber between 1985 to 1990. He was Senior Research Scientist, In Vivo Research (Cancer), at Bayer Pharmaceuticals (Miles Laboratories) during 1991-1993. He had his own veterinary oncology and drug development consultancy practice during 1994. Thereafter, he was Group Leader, Cancer In Vivo Research and Clinical Development, at Eli Lilly and Company during 1995-2001. He was responsible for the development of the anticancer drugs Cryptophycin and the blockbusters, Gemzar and Alimta. He also helped developed another seven compounds at Lilly which are in late clinical phases at present. He has also contributed to the development of an anti-infective drug by Nexus Pharmaceuticals.
Dr. Menon won the Employee of the Year, President's Award at Eli Lilly for 1999. Later, he was the Director of Operations for the ALS Therapy Development Foundation during 2001-2002 (ALS is acute lateral sclerosis, a disease related to Lou Gehrig's Syndrome). He is a Founder and Board Member of KARD Scientific, Cambridge, MA; KARD Inc., Wilmington, MA; as well as KARD Scientific India, Bangalore, India and KARD Medics, Mumbai, India. He is a Director of Biological Supplies, New York, NY. He is a Member of the Scientific Advisory Board of Nexus Pharmaceuticals, Philadelphia, PA and TheraCour Pharma, Inc., West Haven, CT. He is Distinguished Scientist and Scientific Diplomat for GPC-Biotech, Germany. Dr. Menon is a Certified Toxicologist and a Member of the American Association of Toxicology. He holds a VMD from Triniti University, Peru, and MRCS from Royal University of Copenhagen. He is a practicing veterinary surgeon and human physician, licensed in various countries.
Dr. Menon participated in the development of 8 International and 3 US patents, including the one for Alimta. He has been responsible for 7 FDA approved drugs, 3 of which are blockbusters. While at Harvard, he conducted pre-clinical studies on the important anti-HIV drug, AZT. He is well known for his grasp of scientific and regulatory matters in taking a compound from the Chemist's bench to FDA approval. He is regularly invited to lecture across the globe on the drug development process and the regulatory landscape.
- See more at: https://www.crunchbase.com/person/krishna-menon#sthash.P8ZZMxUC.dpuf
Yes a 1 year low, caused by a bear raid. Created a great buying opportunity,
ACanJadaS, Access to capital is predicated on a stable PPS. What we've witnessed the past 3 weeks builds more support for a partnership. A partnership would accomplish 2 things. One, give credibility to those that question the science. And two, support the PPS levels, where an up-listing can occur. Leo tried letting the PPS float on good news, we've seen how that's gone...
A partnership with Eli Lily would make sense, since Dr Menon worked there and should have connections. I'm sure Leo's strategy has changed from counting on a higher PPS, to now supporting a higher PPS (partnership/up-listing)
Need Leo/Meno to buy shares now... A public disclosure would go a long way in supporting the PPS. Those guys should have the funds to buy close to a million shares?
So you believe in the SA article? That's where the credibility issue started. It will take a RS to up-list and get off-the-pinks. Should have been done when the stock was firmly in the high 2's, low 3's... We would not be discussing SA articles at this time.
All this from the result of one article which was all false. Amazing, how easy it is to manipulate stocks on the pinks. I've stressed the need to up-list this entire year... Nasdaq would have contained Thursday's collapse.
Yahoo still shows 2.11...
http://finance.yahoo.com/q?s=CTIX
http://www.nasdaq.com/symbol/ctix/after-hours
Would have liked to see it hold 2, but there's still some fear from that bogus SA article.
Will open up tomorrow above 2. The shorts will soon depart if they haven't already.
I used 70 million, since that was the loss Thursday. We have no idea when the bear raiders shorted? My guess was above 3 as well... Wouldn't surprise me if they took a long position after they covered Thursday/Friday knowing a company response was coming... These guys manipulate the stock up/down... More reasons to get off the pinks...
Bobby, a RS is not a 50 percent loss... A RS raises the PPS to match the decrease in shares owned. Example, Leo announces a 4 for 1 RS, Bobby owns 10k shares currently... After the split, Bobby now owns 2500 shares. The PPS is now 4 times greater. Now, some believe a RS will sink the shares, whereby any effect of up-listing is not worth the chance. However, doing a RS where your company stands to benefit should outweigh any initial sell-off, especially if CTIX has great potential. We've seen the past 3 weeks how unstable trading on the pinks are. The stock hit a high of 3.65 2 weeks ago and a low of 1.35 Friday. So, are we any safer waiting for a higher PPS one-day to up-list? Leo won't do a RS now with all the craziness, but he had an opportunity a few months back and chose not too...
Yes, I've posted the halt/pause structure yesterday from the Nasdaq. I blame 4 enablers for the bear raid. Mako, SA, pink sheets and to a lesser extent Leo. Leo had the up-listing in-hand, but lost approval. First, for not having BOD's, then a falling PPS. I'm a believer that tipping your intent "to shorts" can do more harm than good. Meaning, keep the up-listing process quiet!!! Until one-day, you can make the up-listing official. Nothing to gain by making public your intentions if you can't deliver. It's nice of Leo to be transparent to posters and try to attract new investors, too much info can serve to attract the wrong interest as well...
Up-listing should be the number one focus... Folks here are missing the biggest reason why the bear raid occurred... The pink sheet market... I've stressed the need "at any cost" to up-list, while posters kept saying, "Oh, let the PPS take care of itself". Not only for exposure to new investment, but to have market protection (trading halts) in place. This is exactly why most investors don't buy stocks below a certain level and trade on the pinks.
I agree TOB, Science progression should be the focus now. However, up-listing becomes an even greater priority since there's no protection on-the-downside from these attacks. Nasdaq's (10 percent) decline rule, would have stopped the bears in there tracks. Doesn't matter how great the tech/science is, when an "unverified article" can almost bring down an entire company...
Action should be taken, 70 million of market cap was lost as a result of one article on SA... SA is as much to blame as the short. The longer they leave the article posted, the more liable they become... There were no verified facts from the article, meaning, anyone could/can continue to do the same... Hopefully, more good can come of this, but that will be SA's decision...
Hope Leo has the security cameras checked to see if anyone was there taking those photos? And if so, who it was and if any charges can be brought forward. It's against the law to take unapproved photo's for the sake of profit... This is another liability SA may have?
It was so obvious a hit-piece, SA has nothing to gain by allowing such manipulation. The damage has already been done, SA should review how/why they approve such one-sided garbage. It was more info than an FBI report. Which made it more unreliable the further I read. To disclose pictures of an empty office was comical. Obviously, someone was paid to take those pictures with nobody there...
The allowing of photos of residences and CTIX's workplace is even more reason CTIX should go after SA. The publisher should be as much to blame...
Those who want to contact SA, below link is their contact us section. I used the copyright/legal icon... The more the mightier for removing such garbage. Even a threat of legal action sends them a message...
http://seekingalpha.com/page/contact